Amwill Health Care P/E Ratio
Current P/E Ratio
7.81
Low Valuation
Very Low - Potentially undervalued or facing challenges
Amwill Health Care (AMWILL) P/E ratio is 7.81 (Low), EPS (TTM) ₹5.71, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see Amwill Health Care screener.
Current Valuation Metrics
P/E Ratio
7.81
Current Price
₹
EPS (TTM)
₹5.71
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
54.96
Sector Median
30.69
Sector Rank
#8 of 194
Sector Percentile
4.1%
AMWILL P/E Ratio — Valuation Signal & Historical Context
Amwill Health Care P/E 7.81 — signal: Undervalued. Browse AMWILL complete financial statements for revenue, profit, balance sheet and cash flow data.
- Stock appears undervalued with PE of 7.81, suggesting potential buying opportunity
- Trading at discount to sector average PE of 54.96
AMWILL vs Healthcare Peers — P/E Ratio Comparison
Amwill Health Care P/E 7.81 vs Healthcare average 54.96, median 30.69 — range 2.86–879.0.
Sector Average
54.96
Sector Median
30.69
Lowest P/E
2.86
Highest P/E
879.0
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.5 | ₹30 | Low |
| Phaarmasia | PHRMASI | 4.06 | ₹68 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.97 | ₹7,724 | Low |
| Shelter Pharma | SHELTER | 5.34 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 6.25 | ₹20 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹77 | Low |
| Brooks Laboratories | BROOKS | 8.06 | ₹206 | Low |
| Royal Sense | ROYAL | 8.24 | ₹59 | Low |
| Galaxy Medicare | GML | 8.44 | ₹28 | Low |